Lirafugratinib; RLY-408

Nomen chemicum:

N-[4-(4-amino-5-{3-fluoro-4-[(4-methylpyrimidin-2-yl)oxy]phenyl}-7-methyl-7H-pyrrolo[2,3-d]pyrimidin- 6-yl)phenyl]-2-methylprop-2-enamide

SMILES Code:

C=C(C)C(NC1=CC=C(C2=C(C3=CC=C(OC4=NC=CC(C))=N4)C(F)=C3)C5=C(N)N= CN=C5N2C)C=C1)=O

InChi Code:

InChI=1S/C28H24FN7O2/c1-15(2)27(37)35-19-8-5-17(6-9-19)24-22(23-25(30)32-14-33-26( 23)36(24)4)18-7-10-21(20(29)13-18)38-28-31-12-11-16(3)34-28/h5-14H,1H2,2- H2,30,32,33;

InChi Key:

XOQVZSSDIQQUGO-UHFFFAOYSA-N

Keyword:

2549174-42-5； CAS：2549174-42-5；CAS:2549174-42-5；Lirafugratinib; RLY-4008; RLY 4008; RLY4008

Solubilitas: 

Repono:Arida, obscura et ad 0 - 4 C ad terminum brevem (dies ad septimanas) vel -20 C ad terminum longum (menses ad annos).

Descriptio:

Lirafugratinib (RLY-408) viva voce, immedicabile est, et inhibitor selectivorum FGFR2.

Target: FGFR2